Research programme: skin disorders therapeutics - Almirall SA/Institute for Research in Biomedicine
Latest Information Update: 02 Feb 2022
At a glance
- Originator Almirall S.A.; Institute for Research in Biomedicine
- Class Skin disorder therapies; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Skin disorders